aluates Reports

$ 0.0

Automative

Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-39A16893

BUY CHAPTERS

Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Research Report 2024

Code: QYRE-Auto-39A16893

Report

April 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Airdoc Technology

Digital Diagnostics

Eyenuk

RetinaLyze System

Optomed

Sibionics Technology

AEYE Health

VUNO

Medimaging Integrated Solution

EyRIS (SELENA+)

Vistel

RETINA-AI Health

Acer Medical

Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size

The global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market was valued at US$ 86.8 million in 2023 and is anticipated to reach US$ 6767 million by 2030, witnessing a CAGR of 84.8% during the forecast period 2024-2030.

Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market

Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share

Diabetic retinopathy (DR) represents a major cause of visual impairment in developed countries. The ever-growing incidence of DR and its complications necessitates new strategies to screen patients, prevent complications and optimize management. For this reason, DR is a major target of AI-based models, especially those that can be used for large-scale screening. AI models should recognize DR-related alterations, such as haemorrhages, exudates, cotton wool spots and neovascularization; and, starting from fundus images, establish the presence or absence of DR, and grade it according to the conventional DR grading scales.

Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy.

This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Artificial Intelligence Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Artificial Intelligence Screening System.

North America leads the DR AI screening system market due to high diabetes prevalence, reimbursement support, and telemedicine adoption. Europe follows with national diabetic eye screening programs. Asia-Pacific is rising fast, especially in India and China, with government-driven diabetes awareness campaigns.

Key players such as Eyenuk, Retina-AI Health, and Optos dominate with FDA-approved solutions, real-world validation studies, and scalable platforms. Their ability to integrate with electronic medical records and primary care workflows gives them a competitive edge.

Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Major Factors

The Diabetic Retinopathy (DR) AI Screening System market is growing rapidly due to the global rise in diabetes cases and the need for early detection of vision-threatening complications. AI-based DR screening systems analyze retinal images for signs of microaneurysms, hemorrhages, and neovascularization, enabling early intervention and reducing blindness risk. These tools improve diagnostic accuracy and reduce screening time, especially in underserved areas lacking ophthalmologists. AI screening is increasingly adopted in primary care clinics, mobile health units, and teleophthalmology programs. Supportive reimbursement policies and regulatory approvals for AI diagnostic tools are driving adoption in both developed and emerging healthcare systems.

Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Trends

One major trend is integration of AI DR screening in telehealth platforms. Patients can now undergo retinal screening using portable fundus cameras, with AI interpreting results remotely. This democratizes access to eye care in rural and underserved areas. Health systems are launching mobile eye care vans equipped with AI tools to screen thousands efficiently.

Another trend is the emergence of FDA- and CE-approved AI screening tools. These regulatory green lights are allowing healthcare providers to deploy AI solutions confidently in routine clinical settings. Solutions like IDx-DR and EyeArt are gaining traction in the U.S. and Europe, supporting mass screening programs. Compliance with clinical guidelines is encouraging hospital networks to adopt such tools.

Multilingual and multi-ethnic training data sets are improving AI accuracy. AI screening tools trained on diverse global datasets now exhibit better diagnostic performance across ethnic groups. This enhances applicability in regions with mixed populations and supports global rollout of DR screening services. Vendors are investing in data partnerships with international health organizations to improve fairness and precision.

AI systems are increasingly paired with decision support dashboards. These dashboards provide risk scores, patient history integration, and follow-up recommendations, streamlining the referral process. Primary care doctors can now co-manage diabetic eye health without depending entirely on specialists, reducing bottlenecks in eye care systems and enabling proactive diabetes management.

Market Segmentation

Scope of Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Report

Report Metric	Details
Report Name	Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market
Accounted market size in 2023	US$ 86.8 million
Forecasted market size in 2030	US$ 6767 million
CAGR	84.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Hardware Software
Segment by Application	Medical Institutions Great Health Scene
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel, RETINA-AI Health, Acer Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Artificial Intelligence Screening System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market growing?

Ans: The Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market witnessing a CAGR of 84.8% during the forecast period 2024-2030.

What is the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market size in 2030?

Ans: The Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market size in 2030 will be US$ 6767 million.

Who are the main players in the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market report?

Ans: The main players in the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market are Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel, RETINA-AI Health, Acer Medical

What are the Application segmentation covered in the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market report?

Ans: The Applications covered in the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market report are Medical Institutions, Great Health Scene

What are the Type segmentation covered in the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market report?

Ans: The Types covered in the Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market report are Hardware, Software

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Hardware

1.2.3 Software

1.3 Market by Application

1.3.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Medical Institutions

1.3.3 Great Health Scene

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Perspective (2019-2030)

2.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Growth Trends by Region

2.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Historic Market Size by Region (2019-2024)

2.2.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Region (2025-2030)

2.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Dynamics

2.3.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Industry Trends

2.3.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Drivers

2.3.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Challenges

2.3.4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Revenue

3.1.1 Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Revenue (2019-2024)

3.1.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Players (2019-2024)

3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue

3.4 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Concentration Ratio

3.4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue in 2023

3.5 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System Head office and Area Served

3.6 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Product and Application

3.7 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Breakdown Data by Type

4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Historic Market Size by Type (2019-2024)

4.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Type (2025-2030)

5 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Breakdown Data by Application

5.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Historic Market Size by Application (2019-2024)

5.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)

6.2 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)

6.4 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)

7.2 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)

7.4 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)

8.2 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024)

8.4 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)

9.2 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)

9.4 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)

10.2 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)

10.4 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Airdoc Technology

11.1.1 Airdoc Technology Company Details

11.1.2 Airdoc Technology Business Overview

11.1.3 Airdoc Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.1.4 Airdoc Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.1.5 Airdoc Technology Recent Development

11.2 Digital Diagnostics

11.2.1 Digital Diagnostics Company Details

11.2.2 Digital Diagnostics Business Overview

11.2.3 Digital Diagnostics Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.2.4 Digital Diagnostics Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.2.5 Digital Diagnostics Recent Development

11.3 Eyenuk

11.3.1 Eyenuk Company Details

11.3.2 Eyenuk Business Overview

11.3.3 Eyenuk Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.3.4 Eyenuk Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.3.5 Eyenuk Recent Development

11.4 RetinaLyze System

11.4.1 RetinaLyze System Company Details

11.4.2 RetinaLyze System Business Overview

11.4.3 RetinaLyze System Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.4.4 RetinaLyze System Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.4.5 RetinaLyze System Recent Development

11.5 Optomed

11.5.1 Optomed Company Details

11.5.2 Optomed Business Overview

11.5.3 Optomed Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.5.4 Optomed Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.5.5 Optomed Recent Development

11.6 Sibionics Technology

11.6.1 Sibionics Technology Company Details

11.6.2 Sibionics Technology Business Overview

11.6.3 Sibionics Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.6.4 Sibionics Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.6.5 Sibionics Technology Recent Development

11.7 Aeye Health

11.7.1 Aeye Health Company Details

11.7.2 Aeye Health Business Overview

11.7.3 Aeye Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.7.4 Aeye Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.7.5 Aeye Health Recent Development

11.8 VUNO

11.8.1 VUNO Company Details

11.8.2 VUNO Business Overview

11.8.3 VUNO Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.8.4 VUNO Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.8.5 VUNO Recent Development

11.9 Medimaging Integrated Solution

11.9.1 Medimaging Integrated Solution Company Details

11.9.2 Medimaging Integrated Solution Business Overview

11.9.3 Medimaging Integrated Solution Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.9.4 Medimaging Integrated Solution Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.9.5 Medimaging Integrated Solution Recent Development

11.10 EyRIS (SELENA+)

11.10.1 EyRIS (SELENA+) Company Details

11.10.2 EyRIS (SELENA+) Business Overview

11.10.3 EyRIS (SELENA+) Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.10.4 EyRIS (SELENA+) Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.10.5 EyRIS (SELENA+) Recent Development

11.11 Vistel

11.11.1 Vistel Company Details

11.11.2 Vistel Business Overview

11.11.3 Vistel Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.11.4 Vistel Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.11.5 Vistel Recent Development

11.12 RETINA-AI Health

11.12.1 RETINA-AI Health Company Details

11.12.2 RETINA-AI Health Business Overview

11.12.3 RETINA-AI Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.12.4 RETINA-AI Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.12.5 RETINA-AI Health Recent Development

11.13 Acer Medical

11.13.1 Acer Medical Company Details

11.13.2 Acer Medical Business Overview

11.13.3 Acer Medical Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction

11.13.4 Acer Medical Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

11.13.5 Acer Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Airdoc Technology

Digital Diagnostics

Eyenuk

RetinaLyze System

Optomed

Sibionics Technology

AEYE Health

VUNO

Medimaging Integrated Solution

EyRIS (SELENA+)

Vistel

RETINA-AI Health

Acer Medical

List of Tables

Table 1. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Hardware

Table 3. Key Players of Software

Table 4. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region (2019-2024)

Table 8. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region (2025-2030)

Table 10. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Trends

Table 11. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Drivers

Table 12. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Challenges

Table 13. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Restraints

Table 14. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Players (2019-2024)

Table 16. Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System as of 2023)

Table 17. Ranking of Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Headquarters and Area Served

Table 20. Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Product and Application

Table 21. Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Type (2019-2024)

Table 25. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Type (2025-2030)

Table 27. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Application (2019-2024)

Table 29. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Application (2025-2030)

Table 31. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)

Table 46. Airdoc Technology Company Details

Table 47. Airdoc Technology Business Overview

Table 48. Airdoc Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 49. Airdoc Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 50. Airdoc Technology Recent Development

Table 51. Digital Diagnostics Company Details

Table 52. Digital Diagnostics Business Overview

Table 53. Digital Diagnostics Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 54. Digital Diagnostics Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 55. Digital Diagnostics Recent Development

Table 56. Eyenuk Company Details

Table 57. Eyenuk Business Overview

Table 58. Eyenuk Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 59. Eyenuk Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 60. Eyenuk Recent Development

Table 61. RetinaLyze System Company Details

Table 62. RetinaLyze System Business Overview

Table 63. RetinaLyze System Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 64. RetinaLyze System Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 65. RetinaLyze System Recent Development

Table 66. Optomed Company Details

Table 67. Optomed Business Overview

Table 68. Optomed Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 69. Optomed Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 70. Optomed Recent Development

Table 71. Sibionics Technology Company Details

Table 72. Sibionics Technology Business Overview

Table 73. Sibionics Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 74. Sibionics Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 75. Sibionics Technology Recent Development

Table 76. Aeye Health Company Details

Table 77. Aeye Health Business Overview

Table 78. Aeye Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 79. Aeye Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 80. Aeye Health Recent Development

Table 81. VUNO Company Details

Table 82. VUNO Business Overview

Table 83. VUNO Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 84. VUNO Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 85. VUNO Recent Development

Table 86. Medimaging Integrated Solution Company Details

Table 87. Medimaging Integrated Solution Business Overview

Table 88. Medimaging Integrated Solution Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 89. Medimaging Integrated Solution Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 90. Medimaging Integrated Solution Recent Development

Table 91. EyRIS (SELENA+) Company Details

Table 92. EyRIS (SELENA+) Business Overview

Table 93. EyRIS (SELENA+) Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 94. EyRIS (SELENA+) Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 95. EyRIS (SELENA+) Recent Development

Table 96. Vistel Company Details

Table 97. Vistel Business Overview

Table 98. Vistel Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 99. Vistel Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 100. Vistel Recent Development

Table 101. RETINA-AI Health Company Details

Table 102. RETINA-AI Health Business Overview

Table 103. RETINA-AI Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 104. RETINA-AI Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 105. RETINA-AI Health Recent Development

Table 106. Acer Medical Company Details

Table 107. Acer Medical Business Overview

Table 108. Acer Medical Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product

Table 109. Acer Medical Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)

Table 110. Acer Medical Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Picture

Figure 2. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Type: 2023 VS 2030

Figure 4. Hardware Features

Figure 5. Software Features

Figure 6. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Application: 2023 VS 2030

Figure 8. Medical Institutions Case Studies

Figure 9. Great Health Scene Case Studies

Figure 10. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Report Years Considered

Figure 11. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region: 2023 VS 2030

Figure 14. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Players in 2023

Figure 15. Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue in 2023

Figure 17. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)

Figure 19. United States Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)

Figure 23. Germany Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region (2019-2030)

Figure 31. China Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)

Figure 39. Mexico Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)

Figure 43. Turkey Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Airdoc Technology Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 47. Digital Diagnostics Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 48. Eyenuk Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 49. RetinaLyze System Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 50. Optomed Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 51. Sibionics Technology Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 52. Aeye Health Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 53. VUNO Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 54. Medimaging Integrated Solution Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 55. EyRIS (SELENA+) Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 56. Vistel Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 57. RETINA-AI Health Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 58. Acer Medical Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900